Shouse, Geoffrey
Herrera, Alex F.
Funding for this research was provided by:
Leukemia and Lymphoma Society (2326-19)
Lymphoma Research Foundation (AWD-P060117)
Article History
Accepted: 16 June 2021
First Online: 15 July 2021
Declarations
:
: No external funding was used in the preparation of this article.
: AFH reports research funding from BMS, Merck, Genentech, Inc./F. Hoffmann-La Roche Ltd, Gilead Sciences, Seattle Genetics, AstraZeneca, and ADC Therapeutics and consultancy for BMS, Merck, Genentech, Inc./F. Hoffmann-La Roche Ltd, Kite Pharma/Gilead, Seattle Genetics, Karyopharm, Takeda, Tubulis, AstraZeneca, and ADC Therapeutics. GS received honoraria from Kite Pharmaceuticals for speaking engagements.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: GS and AFH both generated the ideas, designed the tables, and wrote the manuscript.